Impact of rosuvastatin on pulse wave velocity ( PWV) in men with HIV at moderate cardiovascular risk; a sub-study of a multinational, randomized, double blind, placebo-controlled trial

被引:0
|
作者
Hall, V. [1 ]
Trevillyan, J. M. [1 ,2 ]
Dart, A. [3 ]
Dewar, L. [3 ]
Hoy, J. F. [1 ,2 ]
机构
[1] Alfred Hlth Melbourne, Dept Infect Dis, Melbourne, Vic, Australia
[2] Monash Univ, Dept Infect Dis, Cent Clin Sch, Melbourne, Vic, Australia
[3] Alfred Hlth, Dept Cardiol, Melbourne, Vic, Australia
关键词
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
P14
引用
收藏
页码:43 / 43
页数:1
相关论文
共 50 条
  • [41] Double-blind, randomized, placebo-controlled phase III trial of oxymetholone for the treatment of HIV wasting
    Hengge, UR
    Stocks, K
    Wiehler, H
    Faulkner, S
    Esser, S
    Lorenz, C
    Jentzen, W
    Hengge, D
    Goos, M
    Dudley, RE
    Gham, GR
    AIDS, 2003, 17 (05) : 699 - 710
  • [42] Onercept for moderate-to-severe Crohn's disease: A randomized, double-blind, placebo-controlled trial
    Rutgeerts, Paul
    Sandborn, William J.
    Fedorak, Richard N.
    Rachmilewitz, Daniel
    Tarabar, Dino
    Gibson, Peter
    Nielsen, Ole Haagen
    Wild, Gary
    Schreiber, Stefan
    Rossi, Claudia Pena
    Zignani, Monia
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2006, 4 (07) : 888 - 893
  • [43] Pioglitazone as an adjunct to citalopram for moderate to severe major depressive disorder : Randomized double blind placebo-controlled trial
    Modabbernia, A.
    Sepanjnia, K.
    Akhondzadeh, S.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 151 - 151
  • [44] Hypericum treatment of mild-moderate depression in a placebo-controlled study. A prospective, double-blind, randomized, placebo-controlled, multicentre study
    Schrader, E
    Meier, B
    Brattstrom, A
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 1998, 13 (03) : 163 - 169
  • [45] Montelukast treatment of moderate to severe atopic dermatitis in adults: A randomized, double-blind, placebo-controlled trial
    Veien, NK
    Busch-Sorensen, M
    Stausbol-Gron, B
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 53 (01) : 147 - 149
  • [46] Dapagliflozin decreases ambulatory central blood pressure and pulse wave velocity in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial
    Papadopoulou, Eirini
    Loutradis, Charalampos
    Tzatzagou, Glykeria
    Kotsa, Kalliopi
    Zografou, Ioanna
    Minopoulou, Ioanna
    Theodorakopoulou, Marietta P.
    Tsapas, Apostolos
    Karagiannis, Asterios
    Sarafidis, Pantelis
    JOURNAL OF HYPERTENSION, 2021, 39 (04) : 749 - 758
  • [47] Standardized capsule of Camellia sinensis lowers cardiovascular risk factors in a randomized, double-blind, placebo-controlled study
    Nantz, Meri P.
    Rowe, Cheryl A.
    Bukowski, Jack F.
    Percival, Susan S.
    NUTRITION, 2009, 25 (02) : 147 - 154
  • [48] Oxymetholone for the treatment of HIV-wasting: A double-blind, randomized, placebo-controlled phase III trial in eugonadal men and women
    Hengge, UR
    Stocks, K
    Faulkner, S
    Wiehler, H
    Lorenz, C
    Jentzen, W
    Hengge, D
    Ringham, G
    HIV CLINICAL TRIALS, 2003, 4 (03): : 150 - 163
  • [49] Atherosclerotic cardiovascular risk assessment in a 24-week, randomized, double-blind, placebo-controlled study of aldafermin
    Gunn, Nadege T.
    Ling, Lei
    Neff, Guy
    Guy, Cynthia
    Bashir, Mustafa
    Paredes, Angelo
    Frias, Juan
    Younes, Ziad H.
    Trotter, James F.
    Moussa, Sam
    Kohli, Anita
    Connelly, Margery A.
    Nelson, Kristen
    Gottwald, Mildred
    Chang, William
    Yan, Andrew
    DePaoli, Alex
    Lieu, Hsiao
    Harrison, Stephen
    JOURNAL OF HEPATOLOGY, 2021, 75 : S617 - S617
  • [50] A randomized, double-blind placebo-controlled study of the safety of apadenoson in subjects with mild or moderate asthma
    Williams, S. P.
    Mcardle, J. R.
    Colice, G.
    Lankford, A.
    Kajdasz, D. K.
    Reed, C. R.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2011, 13 (0A) : A95 - A96